Vigmed completes rights issue
Vigmed Holding AB has completed a rights issue raising approximately SEK 56 million.
Vigmed is a medical technology company that develops, produces and sells products for elimination of needlestick injuries in the health care sector primarily for the European market. Vigmed is headquartered in Helsingborg, Sweden, and is listed on NASDAQ First North.
Vigmed was advised by Mannheimer Swartling in connection with the rights issue. The firm’s team was led by Anders Lückander, primarily assisted by Åsa Hansdotter and Gustav Engvall.